# ExlService Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2019

- Company: [ExlService Holdings, Inc.](/companies/exls.md) (CIK 1297989)
- Form: 10-Q
- Filed: 2019-10-30
- Accepted by EDGAR: Oct 30, 2019, 09:03 ET
- Period: 2019-09-30
- Accession: 0001297989-19-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297989/000129798919000009/exls-093019x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297989/000129798919000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $251.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $734.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $167.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $487.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $83.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $247.2m | us-gaap:GrossProfit |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | $22.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | $53.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-07-01 to 2019-09-30 | $3.2m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-30 | $10.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | $5.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | $12.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | $19.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | $46.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | $1.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.55 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | $1.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 34,699,497 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 34,744,968 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $106.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $32.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2019-01-01 to 2019-09-30 | $35.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-09-30 | $101.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $506.2m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $1.15bn | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $187.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $498.3m | us-gaap:Liabilities |
| Long-term debt | at 2019-09-30 | $223.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-09-30 | $20.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-09-30 | $647.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 59,539 characters.

*You should read the following discussion in connection with our unaudited consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. Some of the statements in the following discussion are forward looking statements. Dollar amounts within Item 2 are presented as actual, rounded, dollar amounts.*

### Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. These statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances. As you read and consider this Quarterly Report on Form 10-Q, you should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors include but are not limited to:

- our dependence on a limited number of clients in a limited number of industries;
- worldwide political, economic or business conditions;
- negative public reaction in the U.S. or elsewhere to offshore outsourcing;
- fluctuations in our earnings;
- our ability to attract and retain clients including in a timely manner;
- our ability to successfully consummate or integrate strategic acquisitions;
- our ability to accurately estimate and/or manage the costs and/or timing of winding down businesses;
- restrictions on immigration;
- our ability to hire and retain enough sufficiently trained employees to support our operations;
- our ability to grow our business or effectively manage growth and international operations;
- any changes in the senior management team;
- increasing competition in our industry;
- telecommunications or technology disruptions;
- our ability to withstand the loss of a significant customer;
- our ability to realize the entire book value of goodwill and other intangible assets from acquisitions;
- regulatory, legislative and judicial developments, including changes to or the withdrawal of governmental fiscal incentives;
- changes in tax laws or decisions regarding repatriation of funds held abroad;
- ability to service debt or obtain additional financing on favorable terms;
- legal liability arising out of customer contracts;
- technological innovation;
- political or economic instability in the geographies in which we operate;
- cyber security incidents, data breaches, or other unauthorized disclosure of sensitive or confidential client and customer data; and
- adverse outcome of our disputes with the Indian tax authorities.

These and other factors are more fully discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. These and other risks could cause actual results to differ materially from those implied by forward-looking statements in this Quarterly Report on Form 10-Q.

The forward-looking statements made by us in this Quarterly Report on Form 10-Q, or elsewhere, speak only as of the date on which they were made. New risks and uncertainties come up from time to time, and it is impossible for us to predict those events or how they may affect us. We have no obligation to update any forward-looking statements in this Quarterly Report on Form 10-Q after the date of this Quarterly Report on Form 10-Q, except as required by federal securities laws.

### Executive Overview

We are an operations management and analytics company that helps businesses enhance revenue growth and improve profitability. Using proprietary platforms, methodologies, and our full range of digital capabilities, we look deeper to help companies transform their businesses, functions and operations, to help them deliver better customer experience and business outcomes, while managing risk and compliance. We serve our customers in the insurance, healthcare, travel, transportation and logistics, banking and financial services and utilities industries, among others.

We operate in the business process management (“BPM”) industry and we provide operations management and analytics services. Our eight operating segments are strategic business units that align our products and services with how we manage our business, approach our key markets and interact with our clients. Six of those operating segments provide BPM or “operations management” services, which we organize into industry-focused operating segments (Insurance, Healthcare, Travel, Transportation and Logistics, Banking and Financial Services, and Utilities) and one “capability” operating segment (Finance and Accounting) that provides services to clients in our industry-focused segments as well as clients across other industries. In each of these six operating segments we provide operations management services, which typically involve transfer to the Company of business operations of a client, after which we administer and manage those operations for our client on an ongoing basis. Our remaining two operating segments are Consulting, which provides industry-specific digital transformational services related to operations management services, and our Analytics operating segment, which provides services that focus on driving improved business outcomes for clients by generating data-driven insights across all parts of their business.

We present information for the following reportable segments:

- Insurance,
- Healthcare,
- Travel, Transportation and Logistics,
- Finance and Accounting,
- Analytics, and
- All Other (consisting of our remaining operating segments, including our Banking and Financial services, Utilities and Consulting operating segments).

Our global delivery network, which include highly trained industry and process specialists across the United States, Latin America, South Africa, Europe and Asia (primarily India and the Philippines), is a key asset. We have operations centers in India, the U.S., the Philippines, Bulgaria, Colombia, South Africa, Romania and the Czech Republic.

On July 1, 2018, we completed the acquisition of SCIO pursuant to the Merger Agreement. The acquisition of SCIO is included in the Analytics reportable segment. SCIO is a health analytics solution and services company serving over 100 healthcare organizations representing over 130 million covered lives across the continuum, including providers, health plans, pharmacy benefit managers, employers, health services and global life sciences companies.

### Revenues

For the three months ended September 30, 2019, we had revenues of $251.4 million compared to revenues of $231.1 million for the three months ended September 30, 2018, an increase of $20.3 million, or 8.8%. For the nine months ended September 30, 2019, we had revenues of $734.5 million compared to revenues of $648.2 million for the nine months ended September 30, 2018, an increase of $86.3 million, or 13.3%.

We serve clients mainly in the U.S. and the U.K., with these two regions generating 83.0% and 11.1%, respectively, of our total revenues for the three months ended September 30, 2019, and 82.9% and 12.9%, respectively, of our revenues for the three months ended September 30, 2018. For the nine months ended September 30, 2019, these two regions generated 82.1% and 11.9%, respectively, of our total revenues and 82.8% and 13.2%, respectively, of our total revenues for the nine months ended September 30, 2018.

For the three months ended September 30, 2019 and 2018, our total revenues from our top ten clients accounted for 35.7% and 36.7% of our total revenues, respectively. For the nine months ended September 30, 2019 and 2018, our total revenues from our top ten clients accounted for 36.2% and 37.9% of our total revenues, respectively. Our revenue concentration with our top clients remains consistent year-over-year and we continue to develop relationships with new clients to diversify our client base. We believe that the loss of any of our ten largest clients could have a material adverse effect on our financial performance.

### Our Business

We provide operations management and analytics services. We market our services to our existing and prospective clients through our sales and client management teams, which are aligned by key industry verticals and cross-industry domains such as finance and accounting. Our sales and client management teams operate from the U.S., Europe and Australia.

*Operations Management Services:* We provide our clients with a range of operations management services principally in the insurance, healthcare, travel, transportation and logistics, banking and financial services and utilities sectors, among others, as well as cross-industry operations management services, such as finance and accounting services. We also provide services related to operations management, through our Consulting services that provides industry-specific digital transformational services.

Our operations management solutions typically involve the transfer to the Company business operations of a client such as claims processing, clinical operations, or financial transaction processing, after which we administer and manage the operations for our client on an ongoing basis. As part of this transfer, we hire and train employees to work at our operations centers on the relevant business operations, implement a process migration to these operations centers and then provide services either to the client or directly to the client’s customers. Each client contract has different terms based on the scope, deliverables and complexity of the engagement.

We have been observing a shift in industry pricing models toward transaction-based pricing, outcome-based pricing and other pricing models. We believe this trend will continue and we have begun to use such alternative pricing models with some of our current clients and are seeking to move certain other clients from a billing rate model to a transaction-based or other pricing model. These pricing models place the focus on operating efficiency in order to maintain our gross margins. In addition, we have also observed that prospective larger clients are entering into multi-vendor relationships with regard to their outsourcing needs. We believe that the trend toward multi-vendor relationships will continue. A multi-vendor relationship allows a client to seek more favorable pricing and other contract terms from each vendor, which can result in significantly reduced gross margins from the provision of services to such client for each vendor. To the extent our large clients expand their use of multi-vendor relationships and are able to extract more favorable contract terms from other vendors, our gross margins and revenues may be reduced with regard to such clients if we are required to modify the terms of our relationships with such clients to meet competition.

Our existing agreements with original terms of three or more years provide us with a relatively predictable revenue base for a substantial portion of our operations management business, however, we have a long selling cycle for our services and the budget and approval processes of prospective clients make it difficult to predict the timing of entering into definitive agreements with new clients. Similarly, new license sales and implementation projects for our technology service platforms and other software-based services have a long selling cycle, however ongoing annual maintenance and support contracts for existing arrangements provide us with a relatively predictable revenue base.

*Analytics:* Our Analytics services focus on driving improved business outcomes for our customers by generating data-driven insights across all parts of our customers’ business. We also provide care optimization and reimbursement optimization services, for our clients through our healthcare analytics solutions and services. We also offer integrated solutions to help our clients in cost containment by leveraging technology platforms, customizable and configurable analytics and expertise in healthcare reimbursements to help clients enhance their claim payment accuracy. Our teams deliver predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, regulatory reporting, payment integrity and care management and data management. We actively cross-sell and, where appropriate, integrate our Analytics services with other operations management services as part of a comprehensive offering set for our clients.

We anticipate that revenues from our Analytics services will grow as we expand our service offerings and client base, both organically and through acquisitions.

### Critical Accounting Policies and Estimates

For a description of our critical accounting policies and estimates, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” and Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

### Results of Operations

The following table summarizes our results of operations for the three and nine months ended September 30, 2019 and 2018:

*(dollars in millions)*

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Revenues, net | $251.4 | $231.1 | $734.5 | $648.2 |
| Cost of revenues(1) | 167.5 | 152.2 | 487.2 | 429.9 |
| **Gross profit(1)** | **83.9** | **78.9** | **247.3** | **218.3** |
| Operating expenses: |  |  |  |  |
| General and administrative expenses | 29.6 | 28.7 | 93.4 | 85.6 |
| Selling and marketing expenses | 18.3 | 16.4 | 54.0 | 45.6 |
| Depreciation and amortization | 13.1 | 14.1 | 39.5 | 35.2 |
| Impairment and restructuring charges | 0.5 | — | 7.3 | — |
| Total operating expenses | 61.5 | 59.2 | 194.2 | 166.4 |
| **Income from operations** | **22.4** | **19.7** | **53.1** | **51.9** |
| Foreign exchange gain, net | 1.0 | 1.4 | 3.5 | 3.4 |
| Interest expense | (3.2) | (2.5) | (10.6) | (3.7) |
| Other income, net | 4.6 | 2.5 | 13.1 | 8.2 |
| **Income before income tax expense and earnings from equity affiliates** | **24.8** | **21.1** | **59.1** | **59.8** |
| Income tax expense | 5.7 | 5.7 | 12.6 | 6.8 |
| **Income before earnings from equity affiliates** | **19.1** | **15.4** | **46.5** | **53.0** |
| Loss from equity-method investment | 0.1 | 0.1 | 0.2 | 0.2 |
| **Net income attributable to ExlService Holdings, Inc. stockholders** | **$19.0** | **$15.3** | **$46.3** | **$52.8** |

#### (1) Exclusive of depreciation and amortization.

### Three Months Ended September 30, 2019 Compared to Three Months Ended September 30, 2018

### Revenues.

The following table summarizes our revenues by reportable segments for the three months ended September 30, 2019 and 2018:

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Insurance | $77.7 | $64.3 | $13.4 | 20.9% |
| Healthcare | 24.0 | 20.4 | 3.6 | 17.7% |
| Travel, Transportation and Logistics | 17.0 | 17.3 | (0.3) | (1.9)% |
| Finance and Accounting | 26.5 | 24.5 | 2.0 | 8.3% |
| All Other | 17.4 | 21.9 | (4.5) | (20.5)% |
| Analytics | 88.8 | 82.7 | 6.1 | 7.3% |
| Total revenues, net | $251.4 | $231.1 | $20.3 | 8.8% |

Revenues for the three months ended September 30, 2019 were $251.4 million, up $20.3 million, or 8.8%, compared to the three months ended September 30, 2018.

Revenue growth in Insurance of $13.4 million was primarily driven by expansion of business from our new and existing clients of $13.9 million. This was partially offset by $0.5 million mainly attributable to the depreciation of the Australian dollar and U.K. pound sterling against the U.S. dollar during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. Insurance revenues were 30.9% and 27.8% of our total revenues in the three months ended September 30, 2019 and September 30, 2018, respectively.

Revenue growth in Healthcare of $3.6 million was primarily driven by expansion of business from our new and existing clients of $4.4 million. This was partially offset by lower revenues from our Health Integrated business of $0.8 million. Healthcare revenues were 9.5% and 8.8% of our total revenues in the three months ended September 30, 2019 and September 30, 2018, respectively.

Revenue decline in Travel, Transportation and Logistics ("TT&L") of $0.3 million was primarily driven by impact of lower volumes in our existing clients of $0.3 million. TT&L revenues were 6.7% and 7.5% of our total revenues in the three months ended September 30, 2019 and September 30, 2018, respectively.

Revenue growth in Finance and Accounting ("F&A") of $2.0 million was driven by expansion of business from our new and existing clients of $2.1 million. This was partially offset by $0.1 million mainly attributable to the depreciation of the U.K pound sterling against the U.S. dollar during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. F&A revenues were 10.6% of each of our total revenues in the three months ended September 30, 2019 and September 30, 2018.

Revenue decline in All Other of $4.5 million was primarily driven by lower revenue of $3.9 million in our Consulting operating segment, $1.4 million in our Utilities operating segment, partially offset by higher revenue of $0.9 million in our Banking and Financial Services operating segment. The remaining decrease of $0.1 million was due to the depreciation of the U.K. pound sterling against the U.S. dollar during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. All Other revenues were 6.9% and 9.5% of our total revenues in the three months ended September 30, 2019 and September 30, 2018, respectively.

Revenue growth in Analytics of $6.1 million was attributable to our recurring and project-based engagements from our existing clients of $6.4 million. This was partially offset by $0.3 million attributable to the depreciation of the U.K. pound sterling against the U.S. dollar during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. Analytics revenues were 35.3% and 35.8% of our total revenues in the three months ended September 30, 2019 and September 30, 2018, respectively.

***Cost of Revenues and Gross Margin:*** The following table sets forth cost of revenues and gross margin of our reportable segments.

*(dollars in millions)*

|  | Cost of Revenues Three months ended September 30, 2019 | 2018 | Change 2019 | Percentage change 2018 | Gross Margin Three months ended September 30, |  | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Insurance | $51.5 | $43.5 | $8.0 | 18.3% | 33.7% | 32.3% | 1.4% |
| Healthcare | 19.4 | 15.8 | 3.6 | 22.7% | 19.1% | 22.5% | (3.4)% |
| TT&L | 9.8 | 10.0 | (0.2) | (1.6)% | 42.2% | 42.4% | (0.2)% |
| F&A | 16.7 | 15.0 | 1.7 | 11.6% | 37.3% | 39.2% | (1.9)% |
| All Other | 12.3 | 14.3 | (2.0) | (13.5)% | 29.1% | 34.7% | (5.6)% |
| Analytics | 57.8 | 53.6 | 4.2 | 7.8% | 34.8% | 35.1% | (0.3)% |
| Total | $167.5 | $152.2 | $15.3 | 10.1% | 33.4% | 34.2% | (0.8)% |

For the three months ended September 30, 2019, cost of revenues was $167.5 million compared to $152.2 million for the three months ended September 30, 2018, an increase of $15.3 million, or 10.1%. Our gross margin for the three months ended September 30, 2019 was 33.4% compared to 34.2% for three months ended September 30, 2018, a decrease of 80 basis points (“bps”).

The increase in cost of revenues in Insurance of $8.0 million was primarily due to an increase in employee-related costs of $7.2 million on account of higher headcount and wage inflation, increase in technology, travel and infrastructure costs of $1.5 million, partially offset by decrease in other operating costs of $0.2 million and currency movements, net of hedging of $0.5 million. Gross margin in Insurance increased by 140 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to higher revenues.

The increase in cost of revenues in Healthcare of $3.6 million was primarily due to an increase in employee-related costs of $3.5 million on account of higher headcount and wage inflation, increase in technology and travel costs of $0.6 million, partially offset by lower other operating costs of $0.2 million and currency movements, net of hedging of $0.3 million. Gross margin in Healthcare decreased by 340 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to higher employee costs in our existing clients and higher operating expenses associated with the initiation of services for new clients.

The decrease in cost of revenues in TT&L of $0.2 million was primarily due to currency movements, net of hedging of $0.2 million. Gross margin in TT&L decreased by 20 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to lower volumes in existing clients.

The increase in cost of revenues in F&A of $1.7 million was primarily due to higher employee-related costs of $1.4 million and travel costs of $0.3 million. Gross margin in F&A decreased by 190 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to higher operating expenses associated with the initiation of services for new clients.

The decrease in cost of revenues in All Other of $2.0 million was primarily due to a decrease in employee-related costs of $1.8 million, and net decrease in other operating costs of $0.1 million and currency movements, net of hedging of $0.1 million. Gross margin in All Other decreased by 560 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to lower revenues in our Consulting and Utilities operating segments.

The increase in cost of revenues in Analytics of $4.2 million was primarily due to an increase in employee-related costs of $6.2 million on account of higher headcount and wage inflation, partially offset by lower other operating costs of $1.6 million and currency movements, net of hedging of $0.4 million. Gross margin in Analytics decreased by 30 bps during the three months ended September 30, 2019 compared to the three months ended September 30, 2018.

### Selling, General and Administrative (“SG&A”) Expenses.

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| General and administrative expenses | $29.6 | $28.7 | $0.9 | 3.1% |
| Selling and marketing expenses | 18.3 | 16.4 | 1.9 | 11.0% |
| Selling, general and administrative expenses | $47.9 | $45.1 | $2.8 | 6.0% |
| As a percentage of revenues | 19.1% | 19.6% |  |  |

The increase in SG&A expenses of $2.8 million was primarily due to an increase in employee-related costs of $4.6 million and technology costs of $0.4 million. This was partially offset by lower infrastructure and travel costs of $1.4 million, other operating costs of $0.5 million and currency movements, net of hedging of $0.3 million.

### Depreciation and Amortization.

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Depreciation expense | $7.5 | $7.4 | $0.1 | 2.2% |
| Intangible amortization expense | 5.6 | 6.7 | (1.1) | (18.1)% |
| Depreciation and amortization expense | $13.1 | $14.1 | $(1.0) | (7.5)% |
| As a percentage of revenues | 5.2% | 6.1% |  |  |

The decrease in intangibles amortization expense of $1.1 million was primarily due to higher amortization expense during the three months ended September 30, 2018 related to Health Integrated's intangible assets which were impaired during the fourth quarter of 2018, and our SCIO acquisition in July 2018. The increase in depreciation expense of $0.1 million was due to depreciation related to our new operating centers commenced during 2018 to support our business growth.

### Impairment and Restructuring Charges.

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | --- |
| Impairment and restructuring charges | $0.5 | $— | $0.5 | N/A |
| As a percentage of revenues | 0.2% | —% |  |  |

On March 29, 2019, we commenced the process of substantially winding down of the operations of our Health Integrated business, which is reported within the Healthcare reportable segment. During the three months ended September 30, 2019, we recorded restructuring charges of $0.5 million in connection with the wind down process. See Note 24 to our unaudited consolidated financial statements for details.

***Income from Operations.*** Income from operations increased by $2.7 million, or 14.0%, from $19.7 million for the three months ended September 30, 2018 to $22.4 million for the three months ended September 30, 2019. As a percentage of revenues, income from operations increased from 8.5% for the three months ended September 30, 2018 to 8.9% for the three months ended September 30, 2019.

***Foreign Exchange Gain/(Loss).*** Net foreign exchange gains and losses are primarily attributable to movement of the U.S. dollar against the Indian rupee, the U.K. pound sterling and the Philippine peso during the three months ended September 30, 2019. The average exchange rate of the U.S. dollar against the Indian rupee decreased from 70.67 during the three months ended September 30, 2018 to 70.35 during the three months ended September 30, 2019. The average exchange rate of the U.K. pound sterling against the U.S. dollar decreased from 1.31 during the three months ended September 30, 2018 to 1.22 during the three months ended September 30, 2019. The average exchange rate of the U.S. dollar against the Philippine peso decreased from 53.53 during the three months ended September 30, 2018 to 51.59 during the three months ended September 30, 2019.

We recorded a net foreign exchange gain of $1.0 million for the three months ended September 30, 2019 compared to the net foreign exchange gain of $1.4 million for the three months ended September 30, 2018.

***Interest expense.*** Interest expense increased from $2.5 million for the three months ended September 30, 2018 to $3.2 million for the three months ended September 30, 2019 primarily due to interest on our convertible notes and higher effective interest rates on our revolver credit facility.

### Other Income, net.

*(dollars in millions)*

|  | Three months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Gain on sale and mark-to-market of mutual funds | $3.2 | $2.2 | $1.0 | 47.5% |
| Interest and dividend income | 0.5 | 0.5 | — | (6.5)% |
| Other, net | 0.9 | (0.2) | 1.1 | (462.0)% |
| Other income, net | $4.6 | $2.5 | $2.1 | 85.0% |

Other income, net increased by $2.1 million, from $2.5 million for the three months ended September 30, 2018 to $4.6 million for the three months ended September 30, 2019, primarily due to higher return on our mutual fund investments of $1.0 million and increase in one-time other income of $0.8 million related to our Health Integrated acquisition for the three months ended September 30, 2019 compared to the three months ended September 30, 2018.

***Income Tax Expense.*** We recorded income tax expense of $5.7 million each for the three months ended September 30, 2019 and 2018. The effective tax rate decreased from 27.3% during the three months ended September 30, 2018 to 23.0% during the three months ended September 30, 2019, primarily due to the benefits from higher tax incentives in India and the U.S. and lower tax rates for qualifying Indian subsidiaries, offset by lower excess tax benefit during the three months ended September 30, 2019.

***Net Income.*** Net income increased from $15.3 million for the three months ended September 30, 2018 to $19.0 million for the three months ended September 30, 2019, primarily due to increase in income from operations of $2.7 million, higher other income, net of $2.1 million, partially offset by higher interest expense of $0.7 million and lower foreign exchange gain of $0.4 million. As a percentage of revenues, net income increased from 6.6% for the three months ended September 30, 2018 to 7.6% for the three months ended September 30, 2019.

### Nine Months Ended September 30, 2019 Compared to Nine Months Ended September 30, 2018

### Revenues.

The following table summarizes our revenues by reportable segments for the nine months ended September 30, 2019 and 2018:

*(dollars in millions)*

|  | Nine months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Insurance | $219.0 | $193.0 | $26.0 | 13.5% |
| Healthcare | 64.6 | 63.0 | 1.6 | 2.5% |
| Travel, Transportation and Logistics | 51.9 | 53.4 | (1.5) | (2.6)% |
| Finance and Accounting | 78.7 | 72.7 | 6.0 | 8.2% |
| All Other | 56.7 | 66.7 | (10.0) | (15.0)% |
| Analytics | 263.6 | 199.4 | 64.2 | 32.2% |
| Total revenues, net | $734.5 | $648.2 | $86.3 | 13.3% |

Revenues for the nine months ended September 30, 2019 were $734.5 million, up $86.3 million, or 13.3%, compared to the nine months ended September 30, 2018.

Revenue growth in Insurance of $26.0 million was primarily driven by expansion of business from our new and existing clients of $28.5 million. This was partially offset by $2.5 million mainly attributable to the depreciation of the Australian dollar, Indian rupee and U.K. pound sterling against the U.S. dollar during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Insurance revenues were 29.8% each of our total revenues in the nine months ended September 30, 2019 and September 30, 2018.

Revenue increase in Healthcare of $1.6 million was primarily driven by expansion of business from our new and existing clients of $9.6 million, partially offset by lower revenues from our Health Integrated business of $8.0 million. Healthcare revenues were 8.8% and 9.7% of our total revenues in the nine months ended September 30, 2019 and September 30, 2018, respectively.

Revenue decline in Travel, Transportation and Logistics ("TT&L") of $1.5 million was primarily driven by $1.1 million attributable to net lower volumes and $0.4 million attributable to the depreciation of the Indian rupee against the U.S. dollar during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. TT&L revenues were 7.1% and 8.2% of our total revenues in the nine months ended September 30, 2019 and September 30, 2018, respectively.

Revenue growth in Finance and Accounting ("F&A") of $6.0 million was driven by net volume increases from our new and existing clients of $7.0 million. This was partially offset by $1.0 million mainly attributable to the depreciation of the Indian rupee, U.K. pound sterling and Australian dollar against the U.S. dollar during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. F&A revenues were 10.7% and 11.2% of our total revenues in the nine months ended September 30, 2019 and September 30, 2018, respectively.

Revenue decline in All Other of $10.0 million was primarily driven by lower revenues of $6.6 million in our Consulting operating segment, $1.7 million in our Utilities operating segment and $0.3 million in our Banking and Financial Services operating segment. Further decline of $1.4 million was due to the depreciation of the Indian rupee and U.K. pound sterling against the U.S. dollar during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. All Other revenues were 7.7% and 10.3% of our total revenues in the nine months ended September 30, 2019 and September 30, 2018, respectively.

Revenue growth in Analytics of $64.2 million was primarily driven by our acquisition of SCIO in July 2018 contributing $37.9 million during the six months ended June 30, 2019. The remaining increase of $27.5 million was attributable to our recurring and project-based engagements from our new and existing clients. This was partially offset by $1.2 million attributable to the depreciation of the U.K. pound sterling and Indian rupee against the U.S. dollar during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Analytics revenues were 35.9% and 30.8% of our total revenues in the nine months ended September 30, 2019 and September 30, 2018, respectively.

***Cost of Revenues and Gross Margin:*** The following table sets forth cost of revenues and gross margin of our reportable segments.

*(dollars in millions)*

|  | Cost of Revenues Nine months ended September 30, 2019 | 2018 | Change 2019 | Percentage change 2018 | Gross Margin Nine months ended September 30, |  | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Insurance | $148.1 | $130.0 | $18.1 | 13.9% | 32.4% | 32.7% | (0.3)% |
| Healthcare | 53.2 | 49.7 | 3.5 | 7.0% | 17.5% | 21.0% | (3.5)% |
| TT&L | 29.6 | 31.0 | (1.4) | (4.6)% | 43.0% | 41.8% | 1.2% |
| F&A | 46.9 | 44.2 | 2.7 | 6.2% | 40.4% | 39.2% | 1.2% |
| All Other | 37.2 | 44.6 | (7.4) | (16.5)% | 34.4% | 33.2% | 1.2% |
| Analytics | 172.2 | 130.4 | 41.8 | 32.1% | 34.7% | 34.6% | 0.1% |
| Total | $487.2 | $429.9 | $57.3 | 13.3% | 33.7% | 33.7% | —% |

For the nine months ended September 30, 2019, cost of revenues was $487.2 million compared to $429.9 million for the nine months ended September 30, 2018, an increase of $57.3 million, or 13.3%. Our gross margin was 33.7% for both the nine months ended September 30, 2019 and September 30, 2018.

The increase in cost of revenues in Insurance of $18.1 million was primarily due to an increase in employee-related costs of $18.8 million on account of higher headcount and wage inflation and increase in technology, travel and infrastructure cost of $3.4 million. This was partially offset by lower other operating costs of $2.0 million and currency movements, net of hedging of $2.1 million. Gross margin in Insurance decreased by 30 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to higher operating expenses associated with the initiation of services for new clients.

The increase in cost of revenues in Healthcare of $3.5 million was primarily due to an increase in employee-related costs of $4.5 million, technology and travel costs of $0.7 million, partially offset by currency movements, net of hedging of $0.9 million and lower other operating costs of $0.8 million. Gross margin in Healthcare decreased by 350 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the impact of our Health Integrated business and higher employee-related costs.

The decrease in cost of revenues in TT&L of $1.4 million was primarily due to lower infrastructure and other operating costs of $0.8 million and currency movements, net of hedging of $0.6 million. Gross margin in TT&L increased by 120 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to lower operating expenses.

The increase in cost of revenues in F&A of $2.7 million was primarily due to an increase in employee-related costs of $3.2 million on account of higher headcount and wage inflation, partially offset by currency movements, net of hedging of $0.4 million and lower other operating costs of $0.1 million. Gross margin in F&A increased by 120 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to higher margin in existing clients and lower operating expenses.

The decrease in cost of revenues in All Other of $7.4 million was primarily due to a decrease in employee-related costs of $5.3 million, lower travel, infrastructure and other operating costs of $1.3 million and currency movements, net of hedging of $0.8 million. Gross margin in All Other increased by 120 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to better utilization in Banking and Financial Services operating segment and margin improvement in Utilities operating segment.

The increase in cost of revenues in Analytics of $41.8 million was primarily due to an increase in employee-related costs of $37.6 million on account of higher headcount and wage inflation, including incremental cost related to our acquisition of SCIO in July 2018 of $20.0 million during the six months ended June 30, 2019. The remaining increase was attributable to other operating costs of $5.8 million, partially offset by currency movements, net of hedging of $1.6 million. Gross margin in Analytics increased by 10 bps during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

### Selling, General and Administrative (“SG&A”) Expenses.

*(dollars in millions)*

|  | Nine months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| General and administrative expenses | $93.4 | $85.6 | $7.8 | 9.0% |
| Selling and marketing expenses | 54.0 | 45.6 | 8.4 | 18.4% |
| Selling, general and administrative expenses | $147.4 | $131.2 | $16.2 | 12.3% |
| As a percentage of revenues | 20.1% | 20.2% |  |  |

The increase in SG&A expenses of $16.2 million was primarily due to an increase in employee-related costs of $17.1 million, including incremental costs related to our SCIO acquisition in July 2018 of $7.3 million and net increase in other operating costs of $0.6 million. This was partially offset by currency movements, net of hedging of $1.5 million.

### Depreciation and Amortization.

*(dollars in millions)*

|  | Nine months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Depreciation expense | $22.9 | $20.8 | $2.1 | 10.2% |
| Intangible amortization expense | 16.6 | 14.4 | $2.2 | 15.0% |
| Depreciation and amortization expense | $39.5 | $35.2 | $4.3 | 12.2% |
| As a percentage of revenues | 5.4% | 5.4% |  |  |

The increase in intangibles amortization expense of $2.2 million was primarily due to an increase in amortization of intangibles associated with our SCIO acquisition in July 2018, partially offset by the impact of amortization of intangibles related to Health Integrated which were impaired during the fourth quarter of 2018. The increase in depreciation expense of $2.1 million was due to depreciation related to our new operating centers commenced during 2018 to support our business growth and depreciation associated with our SCIO acquisition.

### Impairment and Restructuring Charges.

|  | Nine months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | --- |
| Impairment and restructuring charges | $7.3 | $— | $7.3 | N/A |
| As a percentage of revenues | 1.0% | —% |  |  |

On March 29, 2019, we commenced the process of substantially winding down of the operations of the Health Integrated business, which is reported within the Healthcare reportable segment. During the nine months ended September 30, 2019, we recorded impairment charges of $3.2 million and restructuring charges of $4.1 million in connection with the wind down process. See Note 24 to our unaudited consolidated financial statements for details.

***Income from Operations.*** Income from operations increased by $1.2 million, or 2.4%, from $51.9 million for the nine months ended September 30, 2018 to $53.1 million for the nine months ended September 30, 2019. As a percentage of revenues, income from operations decreased from 8.0% for the nine months ended September 30, 2018 to 7.2% for the nine months ended September 30, 2019.

***Foreign Exchange Gain/(Loss).*** Net foreign exchange gains and losses are primarily attributable to movement of the U.S. dollar against the Indian rupee, the U.K. pound sterling and the Philippine peso during the nine months ended September 30, 2019. The average exchange rate of the U.S. dollar against the Indian rupee increased from 67.61 during the nine months ended September 30, 2018 to 70.03 during the nine months ended September 30, 2019. The average exchange rate of the U.K. pound sterling against the U.S. dollar decreased from 1.35 during the nine months ended September 30, 2018 to 1.27 during the nine months ended September 30, 2019. The average exchange rate of the U.S. dollar against the Philippine peso decreased from 52.64 during the nine months ended September 30, 2018 to 51.84 during the nine months ended September 30, 2019.

We recorded a net foreign exchange gain of $3.5 million for the nine months ended September 30, 2019 compared to the net foreign exchange gain of $3.4 million for the nine months ended September 30, 2018.

***Interest expense.*** Interest expense increased from $3.7 million for the nine months ended September 30, 2018 to $10.6 million for the nine months ended September 30, 2019 primarily due to increase in borrowings and higher effective interest rates under our Credit Facility and issuance of convertible notes.

### Other Income, net.

*(dollars in millions)*

|  | Nine months ended September 30, 2019 | 2018 | Change | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Gain on sale and mark-to-market of mutual funds | $10.1 | $7.0 | $3.1 | 43.6% |
| Interest and dividend income | 2.0 | 1.1 | 0.9 | 70.9% |
| Other, net | 1.0 | 0.1 | 0.9 | 1,509.2% |
| Other income, net | $13.1 | $8.2 | 4.9 | 59.0% |

Other income, net increased by $4.9 million, from $8.2 million for the nine months ended September 30, 2018 to $13.1 million for the nine months ended September 30, 2019, primarily due to a higher return on our mutual fund investments of $3.1 million, increase in interest and dividend income of $0.9 million and increase in one-time other income of $0.8 million, primarily related to our Health Integrated acquisition during the nine months ended September 30, 2019 compared to nine months ended September 30, 2018.

***Income Tax Expense.*** We recorded income tax expense of $12.6 million and $6.8 million for the nine months ended September 30, 2019 and 2018, respectively. The effective tax rate increased from 11.4% during the nine months ended September 30, 2018 to 21.3% during the nine months ended September 30, 2019 primarily as a result of (i) an adjustment of $4.8 million reducing the provisional transition tax on the mandatory deemed repatriation of accumulated earnings and profits ("E&P") of foreign subsidiaries recognized during the nine months ended September 30, 2018 and (ii) recording of excess tax benefits related to stock awards of $1.1 million pursuant to ASU No. 2016-09 during the nine months ended September 30, 2019 compared to $5.4 million during the nine months ended September 30, 2018. See Note 22 to our unaudited consolidated financial statements.

***Net Income.*** Net income decreased from $52.8 million for the nine months ended September 30, 2018 to $46.3 million for the nine months ended September 30, 2019, primarily due to higher interest expense of $6.9 million, higher income tax expense of $5.8 million, partially offset by increase in other income, net of $4.9 million and increase in income from operations of $1.2 million. As a percentage of revenues, net income decreased from 8.2% for the nine months ended September 30, 2018 to 6.3% for the nine months ended September 30, 2019.

### Liquidity and Capital Resources

*(dollars in millions)*

|  | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Opening cash, cash equivalents and restricted cash | $104.1 | $94.3 |
| Net cash provided by operating activities | 106.0 | 47.2 |
| Net cash used for investing activities | (21.3) | (240.4) |
| Net cash (used for)/provided by financing activities | (77.7) | 207.8 |
| Effect of exchange rate changes | (1.8) | (3.1) |
| Closing cash, cash equivalents and restricted cash | $109.3 | $105.8 |

As of September 30, 2019 and 2018, we had $280.8 million and $242.5 million, respectively, in cash, cash equivalents and short-term investments, of which $228.7 million and $187.9 million, respectively, is located in foreign jurisdictions that upon distribution may be subject to withholding and other tax and we do not currently intend to distribute such amounts. If, in the future, we change our intention regarding distributions, additional taxes may be required and would be recorded in the period the intention changes.

*Operating Activities:* Cash flows provided by operating activities were $106.0 million for the nine months ended September 30, 2019 as compared to cash flows provided by operating activities of $47.2 million during the nine months ended September 30, 2018. Generally, factors that affect our earnings—including pricing, volume of services, costs and productivity—affect our cash flows used or provided from operations in a similar manner. However, while management of working capital, including timing of collections and payments affects operating results in an indirect manner, the impact on the working capital and cash flows provided by operating activities can be significant

Cash flows provided by operating activities for the nine months ended September 30, 2019 was $106.0 million. This comprised of net income plus the net effect of non-cash items, such as depreciation and amortization, stock-based compensation expense, amortization of operating lease right-of-use assets, deferred income taxes, impairment charges and others aggregating to $119.2 million. The primary working capital use of cash of $39.0 million during the nine months ended September 30, 2019 was driven by an increase in accounts receivables, other assets and decrease in operating lease liabilities, accounts payable. The primary working capital sources of cash of $25.8 million was driven by an increase in accrued expenses and other liabilities, accrued employee costs, deferred revenue and decrease in advance income tax, prepaid expenses and other current assets.

*Investing Activities:* Cash flows used for investing activities were $21.3 million for the nine months ended September 30, 2019 as compared to cash flows used for investing activities of $240.4 million for the nine months ended September 30, 2018. The decrease is mainly due to higher cash used for the business acquisitions of $231.9 million during the nine months ended September 30, 2018. This was partially offset by lower net proceeds from redemption of investments of $11.2 million during the nine months ended September 30, 2019 as compared to higher net proceeds from redemption of investments of $21.6 million during the nine months ended September 30, 2018 and higher capital expenditures for purchase of long-lived assets, including investments in infrastructure, technology applications, product developments, digital technology and advanced automation & robotics of $2.2 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

*Financing Activities:* Cash flows used for financing activities were $77.7 million during the nine months ended September 30, 2019 as compared to cash flows provided by financing activities of $207.8 million during the nine months ended September 30, 2018. The decrease in cash flows provided from financing activities was primarily due to higher net borrowings of $239.9 million (net of proceeds) under our Credit Facility (as described below in “Financing Arrangements”) during the nine months ended September 30, 2018 as compared to net repayments of $41.8 million and higher purchases of treasury stock by $3.1 million under our share repurchase program during the nine months ended September 30, 2019 as compared to the nine months ended September 30, 2018.

We expect to use cash from operating activities to maintain and expand our business by making investments primarily related to new facilities and capital expenditures associated with leasehold improvements to build our facilities, and purchase telecommunications equipment and computer hardware and software in connection with managing client operations. We incurred $32.3 million of capital expenditures in the nine months ended September 30, 2019. We expect to incur capital expenditures of between $38.0 million to $42.0 million in 2019, primarily to meet our growth requirements, including additions to our facilities as well as investments in technology applications, product development, digital technology, advanced automation & robotics and infrastructure.

In connection with any tax assessment orders that have been issued or may be issued against us or our subsidiaries, we may be required to deposit additional amounts with respect to such assessment orders (see Note 26 to our unaudited consolidated financial statements herein for further details). We anticipate that we will continue to rely upon cash from operating activities to finance our smaller acquisitions, capital expenditures and working capital needs. If we have significant growth through acquisitions, we may need to obtain additional financing.

### Financing Arrangements (Debt Facility)

#### Revolver Credit Agreement

On November 21, 2017, we and each of our wholly owned material domestic subsidiaries entered into a Credit Agreement with certain lenders, and Citibank, N.A. as Administrative Agent (the “Credit Agreement”). The Credit Agreement provides for a $200.0 million revolving credit facility (the “Credit Facility”) with an option to increase the commitments by up to

$100.0 million, subject to certain approvals and conditions as set forth in the Credit Agreement. The Credit Agreement also includes a letter of credit sub facility. The Credit Facility has a maturity date of November 21, 2022 and is voluntarily pre-payable from time to time without premium or penalty. Borrowings under the Credit Agreement may be used for working capital and general corporate purposes, including permitted acquisitions. On July 2, 2018, we exercised our option under the Credit Agreement to increase the commitments by $100.0 million thereby utilizing the entire revolver under the Credit Facility of $300.0 million, to fund the SCIO acquisition. The incremental commitments were made pursuant to (and constitute part of) the existing commitments and shall be subject to the terms and conditions applicable to the existing commitments as set forth in the Credit Agreement.

We entered into a second amendment (the “Amendment”) to our Credit Agreement, as amended, among the Company, as borrower, with certain lenders, and Citibank, N.A. as Administrative Agent to, among other things, permit the issuance by us of the convertible notes, and settlement upon maturity or conversion thereof, in accordance with the Investment Agreement, the indenture dated as of October 4, 2018 and the other documents entered into in connection therewith.

See Note 18 to our unaudited consolidated financial statements herein for further details on our debt facilities.

As of September 30, 2019, we had outstanding indebtedness under the credit facility of $109.0 million, of which $20.0 million is expected to be repaid within the next twelve months and is included under “current portion of long-term borrowings” and of which $89.0 million is included under “long-term borrowings” in the unaudited consolidated balance sheets. As of December 31, 2018, we had outstanding indebtedness under the credit facility of $150.0 million, of which $20.0 million was presented under "current portion of long-term borrowings" and the balance of $130.0 million was included under "long-term borrowings" in the unaudited consolidated balance sheets.

#### Convertible Senior Notes

On October 1, 2018, we entered into an investment agreement (the “Investment Agreement”) with Orogen Echo LLC (the “Purchaser”), an affiliate of The Orogen Group LLC, relating to the issuance to the Purchaser of $150.0 million in an aggregate principal amount of 3.50% Convertible Senior Notes due October 1, 2024 (the "Notes"). The transactions contemplated by the Investment Agreement, including the issuance of the Notes, closed on October 4, 2018. The Notes bear interest at a rate of 3.50% per annum, payable semi-annually in arrears in cash on April 1 and October 1 of each year. During the three and nine months ended September 30, 2019, we recognized interest expense of $1.3 million and $3.9 million. The Notes are convertible at an initial conversion rate of 13.3333 shares of the common stock per $1,000 principal amount of the Notes (which represents an initial conversion price of approximately $75 per share). With certain exceptions, upon a fundamental change, as defined in the Indenture, the holders of the Notes may require us to repurchase all or part of the principal amount of the Notes at a purchase price equal to the principal amount plus accrued and unpaid interest. We may redeem the principal amount of the Notes, at our option, in whole but not in part, at a purchase price equal to the principal amount plus accrued and unpaid interest on or after October 1, 2021, if the closing sale price of the common stock exceeds 150% of the then-current conversion price for 20 or more trading days in the 30 consecutive trading day period preceding our exercise of this redemption right (including the trading day immediately prior to the date of the notice of redemption). We may elect to settle conversions of the Notes by paying or delivering, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock. We used the proceeds from the issuance of Notes to repay $150.0 million of our outstanding borrowings under the Credit Facility.

We accounted for the liability and equity components of the Notes separately to reflect its non-convertible debt borrowing rate. The estimated fair value of the liability component at issuance of $133.1 million was determined using a discounted cash flow technique, which considered debt issuances with similar features of our debt, excluding the conversion feature. The resulting effective interest rate for the Notes was 5.75% per annum. The excess of the gross proceeds received over the estimated fair value of the liability component totaling $16.9 million, excluding tax effects, was allocated to the conversion feature (equity component, recorded as additional paid-in capital) with a corresponding offset recognized as a discount to reduce the net carrying value of the Notes. The discount is being amortized to interest expense over a six-year period ending October 1, 2024 (the expected life of the liability component) using the effective interest method.

Under the terms of the Notes, we are not prohibited from paying cash dividends unless payment would trigger an event of default or if one currently exists. We do not anticipate paying any cash dividends in the foreseeable future.

### Off-Balance Sheet Arrangements

In the ordinary course of business, we provide standby letters of credit to third parties primarily for facility leases. As of September 30, 2019 and December 31, 2018, we had outstanding letters of credit of $0.5 million and $nil, respectively, that were not recognized in our consolidated balance sheets. These are not reasonably likely to have, a current or future material effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. We had no other off balance sheet arrangements or obligations.

### Contractual Obligations

The following table sets forth our contractual obligations as of September 30, 2019:

*(dollars in millions)*

|  | Payment Due by Period Less than 1 year | 1-3 years | 4-5 years | After 5 years | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Finance leases | $0.3 | $0.4 | $0.1 | $— | $0.8 |
| Operating leases(a) | 25.5 | 44.2 | 34.6 | 26.0 | 130.3 |
| Purchase obligations | 5.9 | — | — | — | 5.9 |
| Other obligations(b) | 1.8 | 3.3 | 2.8 | 4.6 | 12.5 |
| Borrowings: |  |  |  |  |  |
| Principal payments | 20.9 | 68.5 | 21.0 | 150.0 | 260.4 |
| Interest payments(c) | 8.4 | 14.0 | 10.8 | 2.6 | 35.8 |
| Total contractual cash obligations(d) | $62.8 | $130.4 | $69.3 | $183.2 | $445.7 |

*(a) Represents lease liabilities payable for cancellable and non-cancellable lease period.*

#### (b) Represents estimated payments under the Gratuity Plan.

*(c) Interest on borrowings is calculated based on the interest rate on the outstanding borrowings as of September 30, 2019.*

*(d) Excludes $0.8 million related to uncertain tax positions, since the extent of the amount and timing of payment is currently not reliably estimable or determinable.*

Certain units of our Indian subsidiaries were established as 100% Export-Oriented units under the “STPI” scheme promulgated by the Government of India. These units are exempt from customs, central excise duties, and levies on imported and indigenous capital goods, stores, and spares. We have undertaken to pay custom duties, service taxes, levies, and liquidated damages payable, if any, in respect of imported and indigenous capital goods, stores, and spares consumed duty free, in the event that certain terms and conditions are not fulfilled. We believe, however, that these units have in the past satisfied and will continue to satisfy the required conditions.

Our operations centers in the Philippines are registered with the “PEZA.” The registration provides us with certain fiscal incentives on the import of capital goods and requires that ExlService Philippines, Inc. meet certain performance and investment criteria. We believe that these centers have in the past satisfied and will continue to satisfy the required criteria.

### Recent Accounting Pronouncements

For a description of recent accounting pronouncements, see Note 2—“Recent Accounting Pronouncements” to the unaudited consolidated financial statements contained herein.

## Market risk

As filed, 356 characters.

During the three months ended September 30, 2019, there were no material changes in our market risk exposure. For a discussion of our market risk associated with exchange rate risk and interest rate risk, see Item 7A “Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

## Controls and procedures

As filed, 1,443 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), to allow timely decisions regarding required disclosure. In connection with the preparation of this Quarterly Report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of the CEO and CFO, of the effectiveness and operation of our disclosure controls and procedures as of September 30, 2019. Based upon that evaluation, the CEO and CFO have concluded that, as of September 30, 2019, our disclosure controls and procedures were effective.

### Changes in Internal Control over Financial Reporting

During the three months ended September 30, 2019, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 732 characters.

We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 a number of risks which may materially affect our business, financial condition or results of operations. You should carefully consider the “Risk Factors” set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and the other information set forth elsewhere in this Quarterly Report on Form 10-Q. You should be aware that these risk factors and other information may not describe every risk facing our Company. Additional risks and uncertainties not currently known to us may also materially adversely affect our business, financial condition and/or results of operations.

Filed Oct 30, 2019.
Source: SEC EDGAR, the filing index for accession 0001297989-19-000009. Last ingested by Listed: Nov 14, 2026, 12:47 ET. No prices; not investment advice.
